BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33505922)

  • 1. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus.
    Hutcheson RL; Chakravorty A; Sugden B
    Front Cell Infect Microbiol; 2020; 10():606412. PubMed ID: 33505922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
    Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
    Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes.
    Sidorov S; Fux L; Steiner K; Bounlom S; Traxel S; Azzi T; Berisha A; Berger C; Bernasconi M; Niggli FK; Perner Y; Pather S; Kempf W; Nadal D; Bürgler S
    Cancer Immunol Immunother; 2022 Jun; 71(6):1371-1392. PubMed ID: 34668039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
    Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof for EBV's sustaining role in Burkitt's lymphomas.
    Vereide D; Sugden B
    Semin Cancer Biol; 2009 Dec; 19(6):389-93. PubMed ID: 19628040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
    Molina E; García-Gutiérrez L; Junco V; Perez-Olivares M; de Yébenes VG; Blanco R; Quevedo L; Acosta JC; Marín AV; Ulgiati D; Merino R; Delgado MD; Varela I; Regueiro JR; Moreno de Alborán I; Ramiro AR; León J
    Oncogene; 2023 Nov; 42(45):3358-3370. PubMed ID: 37773203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
    Kaymaz Y; Oduor CI; Yu H; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
    Mol Cancer Res; 2017 May; 15(5):563-576. PubMed ID: 28465297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling genome-wide recombination in Epstein Barr virus reveals type-specific patterns and associations with endemic-Burkitt lymphoma.
    Agwati EO; Oduor CI; Ayieko C; Ong'echa JM; Moormann AM; Bailey JA
    Virol J; 2022 Dec; 19(1):208. PubMed ID: 36482473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
    Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
    J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomas differ in their dependence on Epstein-Barr virus.
    Vereide DT; Sugden B
    Blood; 2011 Feb; 117(6):1977-85. PubMed ID: 21088132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
    Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
    PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.